Literature DB >> 22370339

Synthesis, antimicrobial and anticancer activities of a novel series of diphenyl 1-(pyridin-3-yl)ethylphosphonates.

Mohamed F Abdel-Megeed1, Badr E Badr, Mohamed M Azaam, Gamal A El-Hiti.   

Abstract

A novel series of diphenyl 1-(arylamino)-1-(pyridin-3-yl)ethylphosphonates 1-5 was obtained in high yields from reactions of 3-acetyl pyridine with aromatic amines and triphenylphosphite in the presence of lithium perchlorate as a catalyst. The structures of the synthesized compounds were confirmed by IR, (1)H NMR spectral data and microanalyses. Compounds 1-5 showed high antimicrobial activities against Escherichia coli (NCIM2065) as a Gram-negative bacterium, Bacillus subtilis (PC1219) and Staphylococcus aureus (ATCC25292) as Gram-positive bacteria and Candidaalbicans and Saccharomyces cerevisiae as fungi, at low concentrations (10-100 μg/mL). Also, the synthesized compounds showed significant cytotoxicity anticancer activities against liver carcinoma cell line (HepG2) and human breast adenocarcinoma cell line (MCF7). The lethal dose of the synthesized compounds was also determined and indicated that most compounds are safe to use.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22370339     DOI: 10.1016/j.bmc.2012.02.015

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

Review 1.  Synthesis of sulfur-containing heterocycles via ring enlargement.

Authors:  Bakr F Abdel-Wahab; Saad Shaaban; Gamal A El-Hiti
Journal:  Mol Divers       Date:  2018-01-31       Impact factor: 2.943

Review 2.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

3.  Crystal structure of 2,2-dimethyl-N-(5-methyl-pyridin-2-yl)propanamide.

Authors:  Gamal A El-Hiti; Keith Smith; Amany S Hegazy; Saud A Alanazi; Benson M Kariuki
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-05-23

4.  Crystal structure of 2,2-dimethyl-N-(pyridin-3-yl)propanamide.

Authors:  Gamal A El-Hiti; Keith Smith; Amany S Hegazy; Saud A Alanazi; Benson M Kariuki
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-03-21

5.  2,2-Dimethyl-N-(4-methyl-pyridin-2-yl)propanamide.

Authors:  Gamal A El-Hiti; Keith Smith; Asim A Balakit; Amany S Hegazy; Benson M Kariuki
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-02-26

6.  Cytotoxicity anticancer activities of anastrozole against breast, liver hepatocellular, and prostate cancer cells.

Authors:  Firas Hassan; Gamal A El-Hiti; Mays Abd-Allateef; Emad Yousif
Journal:  Saudi Med J       Date:  2017-04       Impact factor: 1.484

7.  Octahydroquinoxalin-2(1H)-One-Based Aminophosphonic Acids and Their Derivatives-Biological Activity Towards Cancer Cells.

Authors:  Jakub Iwanejko; Elżbieta Wojaczyńska; Eliza Turlej; Magdalena Maciejewska; Joanna Wietrzyk
Journal:  Materials (Basel)       Date:  2020-05-22       Impact factor: 3.623

8.  Investigation of the Anticancer Effect of α-Aminophosphonates and Arylidine Derivatives of 3-Acetyl-1-aminoquinolin-2(1H)-one on the DMBA Model of Breast Cancer in Albino Rats with In Silico Prediction of Their Thymidylate Synthase Inhibitory Effect.

Authors:  Mohamed A Nassan; Adil Aldhahrani; Hamada H Amer; Ahmed Elhenawy; Ayman A Swelum; Omar M Ali; Yasser H Zaki
Journal:  Molecules       Date:  2022-01-24       Impact factor: 4.411

Review 9.  The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design.

Authors:  Yong Ling; Zhi-You Hao; Dong Liang; Chun-Lei Zhang; Yan-Fei Liu; Yan Wang
Journal:  Drug Des Devel Ther       Date:  2021-10-13       Impact factor: 4.162

10.  Crystal structure of 1-benzyl-4-(2,4-di-chloro-phenyl)-2-imino-1,2,5,6,7,8,9,10-octa-hydro-cyclo-octa-[b]pyridine-3-carbo-nitrile.

Authors:  R A Nagalakshmi; J Suresh; S Maharani; R Ranjith Kumar; P L Nilantha Lakshman
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.